Press Releases
Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.
Bora Biologics Celebrates Opening of $30 Million San Diego Manufacturing Expansion
Thursday, January 29, 2026Biologics a contract drug manufacturing organization specializing in microbial and mammalianexpressed therapeutics celebrated the opening of its expanded FDAapproved manufacturing facility in San Diego
IXCells Biotechnologies and Rosebud Biosciences Partner to Advance Organoid-Based Models for Rare Diseases
Wednesday, January 28, 2026IXCells Biotechnologies iXCells a leading provider of human cellbased solutions and custom iPSC services and Rosebud Biosciences an innovator in organoid development and complex D biology today announced
Innovent Announces IBI3003 (GPRC5D/BCMA/CD3 Trispecific Antibody) Receives Fast Track Designation from the U.S. FDA for Relapsed or Refractory Multiple Myeloma
Wednesday, January 28, 2026Innovent Biologics Inc Innovent HKEX a worldclass biopharmaceutical company that develops manufactures and commercializes highquality medicines for the treatment of oncologic autoimmune
Boehringer Ingelheim’s investigational asset apecotrep delivers proteinuria reduction in Phase II kidney trial
Wednesday, January 28, 2026Boehringer Ingelheim today announced results from a week Phase II clinical trial evaluating apecotrep BI an oral potential firstinclass nonimmunosuppressive TRPC inhibitor for people with primary
Genethon Advances Groundbreaking Gene Therapies for Patients with Rare Genetic Diseases
Tuesday, January 27, 2026Genethon a unique nonprofit gene therapy RD organization founded by the French Muscular Dystrophy Association AFMTelethon began the new year with an RD licensing deal for its gene therapy approach to Pompe disease
MetP Pharma’s Enabling Technology Creates a New Brain-Targeted GLP-1 Opportunity
Friday, January 23, 2026MetP Pharma AG a pioneer in nosetobrain drug delivery today announced new preclinical data demonstrating that its proprietary nasal technology achieves rapid dosedependent brain targeting of GLPbased drugs such as semaglutide while maintaining
Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughput Kinase Inhibitor Screening
Wednesday, January 21, 2026Sino Biological Inc is proud to announce the launch of its innovative SwiftFluo TRFRET Kinase Assay Kits a readytouse highperformance solution designed to accelerate kinase activity detection and highthroughput kinase inhibitor screening
Lantern Pharma's LP-284 Receives FDA Orphan Drug Designation for Soft Tissue Sarcomas
Wednesday, January 21, 2026Lantern Pharma Inc a clinicalstage biopharmaceutical company using artificial intelligence to transform the cost pace and timeline of oncology drug discovery and development today announced that the US Food and Drug Administration
ENHERTU® Plus Pertuzumab Type II Variation Application Validated in the EU as First-Line Treatment of Patients with HER2 Positive Metastatic Breast Cancer
Tuesday, January 20, 2026The European Medicines Agency EMA has validated the Type II Variation marketing authorization application for ENHERTU trastuzumab deruxtecan in combination with pertuzumab for the firstline treatment
InterAx and Alveus Announce Strategic Licensing and Research Agreement to Develop a Differentiated Therapeutic Candidate for a Metabolic Disease
Friday, January 16, 2026InterAx Biotech Ltd InterAx and Alveus Therapeutics Inc Alveus today announced a strategic licensing and research collaboration agreement to develop a differentiated small molecule candidate for metabolic disease
